Overview

Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this research study is to test the hypothesis that late sodium current blocking drugs (mexiletine or lidocaine) can attenuate the effect of hERG potassium channel blocking drugs (dofetilide) on ventricular repolarization (QTc) by shortening early repolarization (J-Tpeakc). The secondary object is to assess the ability of calcium channel block (diltiazem) to reduce the QTc prolongation associated with hERG block (moxifloxacin).
Phase:
Phase 1
Details
Lead Sponsor:
Food and Drug Administration (FDA)
Collaborator:
Spaulding Clinical Research LLC
Treatments:
Diltiazem
Dofetilide
Fluoroquinolones
Lidocaine
Mexiletine
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination